Unknown

Dataset Information

0

Genetic susceptibility to distinct bladder cancer subphenotypes.


ABSTRACT: BACKGROUND:Clinical, pathologic, and molecular evidence indicate that bladder cancer is heterogeneous with pathologic/molecular features that define distinct subphenotypes with different prognoses. It is conceivable that specific patterns of genetic susceptibility are associated with particular subphenotypes. OBJECTIVE:To examine evidence for the contribution of germline genetic variation to bladder cancer heterogeneity. DESIGN, SETTING, AND PARTICIPANTS:The Spanish Bladder Cancer/EPICURO Study is a case-control study based in 18 hospitals located in five areas in Spain. Cases were patients with a newly diagnosed, histologically confirmed, urothelial cell carcinoma of the bladder from 1998 to 2001. Case diagnoses were reviewed and uniformly classified by pathologists following the World Health Organisation/International Society of Urological Pathology 1999 criteria. Controls were hospital-matched patients (n=1149). MEASUREMENTS:A total of 1526 candidate variants in 423 candidate genes were analysed. Three distinct subphenotypes were defined according to stage and grade: low-grade nonmuscle invasive (n=586), high-grade nonmuscle invasive (n=219), and muscle invasive (n=246). The association between each variant and subphenotype was assessed by polytomous risk models adjusting for potential confounders. Heterogeneity in genetic susceptibility among subphenotypes was also tested. RESULTS AND LIMITATIONS:Two established bladder cancer susceptibility genotypes, NAT2 slow-acetylation and GSTM1-null, exhibited similar associations among the subphenotypes, as did VEGF-rs25648, which was previously identified in our study. Other variants conferred risks for specific tumour subphenotypes such as PMS2-rs6463524 and CD4-rs3213427 (respective heterogeneity p values of 0.006 and 0.004), which were associated with muscle-invasive tumours (per-allele odds ratios [95% confidence interval] of 0.56 [0.41-0.77] and 0.71 [0.57-0.88], respectively) but not with non-muscle-invasive tumours. Heterogeneity p values were not robust in multiple testing according to their false-discovery rate. CONCLUSIONS:These exploratory analyses suggest that genetic susceptibility loci might be related to the molecular/pathologic diversity of bladder cancer. Validation through large-scale replication studies and the study of additional genes and single nucleotide polymorphisms are required.

SUBMITTER: Guey LT 

PROVIDER: S-EPMC3220186 | biostudies-literature | 2010 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Background</h4>Clinical, pathologic, and molecular evidence indicate that bladder cancer is heterogeneous with pathologic/molecular features that define distinct subphenotypes with different prognoses. It is conceivable that specific patterns of genetic susceptibility are associated with particular subphenotypes.<h4>Objective</h4>To examine evidence for the contribution of germline genetic variation to bladder cancer heterogeneity.<h4>Design, setting, and participants</h4>The Spanish Bladder  ...[more]

Similar Datasets

| S-EPMC3664723 | biostudies-literature
| S-EPMC5929300 | biostudies-literature
| S-EPMC2912840 | biostudies-literature
| S-EPMC3172962 | biostudies-literature
| S-EPMC9575197 | biostudies-literature
| S-EPMC9258647 | biostudies-literature
| S-EPMC3527453 | biostudies-literature
| S-EPMC4734791 | biostudies-literature
| S-EPMC9554954 | biostudies-literature